DELAYED TREATMENT WITH AMPA BUT NOT NMDA GLUTAMATE ANTAGONISTS REDUCES NEOCORTICAL INFARCTION

DELAYED TREATMENT WITH AMPA BUT NOT NMDA GLUTAMATE ANTAGONISTS REDUCES NEOCORTICAL INFARCTION

Detalles Bibliográficos
Main Authors:	Xue, D, Huang, Z, Smith, K, Lesiuk, H, Buchan, A
Formato:	Journal article
Publicado:	1992

Títulos similares

Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
por: Xue, D, et al.
Publicado: (1994)

POSTISCHEMIC TREATMENT WITH AMPA, BUT NOT NMDA, ANTAGONISTS PREVENTS CA1 NEURONAL INJURY
por: Li, H, et al.
Publicado: (1992)

AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?
por: Buchan, A, et al.
Publicado: (1993)

Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia.
por: Buchan, A, et al.
Publicado: (1991)

Ionotropic Glutamate Receptors in Epilepsy: A Review Focusing on AMPA and NMDA Receptors
por: Takahisa Hanada
Publicado: (2020-03-01)

NMDA antagonists: their role in neuroprotection.
por: Small, D, et al.
Publicado: (1997)

NMDA antagonists: their role in neuroprotection.
por: Small, D, et al.
Publicado: (1997)

MK-801 REDUCES THE VOLUME OF NEOCORTICAL INFARCTION BUT ALSO INCREASES REGIONAL CEREBRAL BLOOD-FLOW
por: Buchan, A, et al.
Publicado: (1990)

The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke.
por: Buchan, A, et al.
Publicado: (1992)

Do NMDA antagonists prevent neuronal injury? No.
por: Buchan, A
Publicado: (1992)

The rise and fall of NMDA antagonists for ischemic stroke.
por: Hoyte, L, et al.
Publicado: (2004)

AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro.
por: Falko Lange, et al.
Publicado: (2019-01-01)

Facilitation of neocortical presynaptic terminal development by NMDA receptor activation
por: Sceniak Michael P, et al.
Publicado: (2012-02-01)

Аlterationdegree of NMDA and AMPA receptors of glutamate in the pathogenesis of the disease and technological peculiarities of surgical treatment of the hemispheric glioma-swith the epileptic syndrome
por: V. N. Ochkolyas, et al.
Publicado: (2014-06-01)

Modulation of NMDA and AMPA/kainate receptors by tocotrienol-rich fraction and α-tocopherol in glutamate- induced injury of primary astrocytes
por: Abedi, Zahra
Publicado: (2017)

The modulation of NMDA and AMPA/kainate receptors by tocotrienol-rich fraction and A-tocopherol in glutamate-induced injury of primary astrocytes
por: Abedi, Zahra, et al.
Publicado: (2017)

NMDA Receptor Antagonists for Treatment of Depression
por: Zeynep Ates-Alagoz, et al.
Publicado: (2013-04-01)

U74006F REDUCES NEOCORTICAL INFARCTION BUT DOES NOT ATTENUATE SELECTIVE HIPPOCAMPAL CA1 NECROSIS
por: Dong, X, et al.
Publicado: (1990)

Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted?
por: Buchan, A
Publicado: (1990)

Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia.
por: Hicks, C, et al.
Publicado: (1999)

How microelectrode array-based chick forebrain neuron biosensors respond to glutamate NMDA receptor antagonist AP5 and GABAA receptor antagonist musimol
por: Serena Y. Kuang, et al.
Publicado: (2016-09-01)

CP-465,022, a selective noncompetitive AMPA receptor antagonist, blocks AMPA receptors but is not neuroprotective in vivo.
por: Menniti, F, et al.
Publicado: (2003)

NMDA receptor antagonists in the treatment of neurological diseases
por: I. S. Preobrazhenskaya
Publicado: (2020-10-01)

Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury.
por: Li, H, et al.
Publicado: (1993)

The earliest neuronal responses to hypoxia in the neocortical circuit are glutamate-dependent
por: Omer Revah, et al.
Publicado: (2016-11-01)

Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation
por: Daniela Bonini, et al.
Publicado: (2016-01-01)

Neuroprotection, excitotoxicicity and nmda antagonists
por: RUBENS JOSÉ GAGLIARDI
Publicado: (2000-06-01)

Immediate or delayed mild hypothermia prevents focal cerebral infarction.
por: Xue, D, et al.
Publicado: (1992)

HYPOTHERMIA BUT NOT NMDA RECEPTOR ANTAGONIST MK-801 ATTENUATES NEURON DAMAGE - ARE THE RESULTS CONCLUSIVE - REPLY
por: Buchan, A, et al.
Publicado: (1992)

NEUROPROTECTIVE PROFILE OF FPL-15896AR, A NOVEL UNCOMPETITIVE NMDA ANTAGONIST
por: Murray, R, et al.
Publicado: (1995)

Differential modulation of NMDA and AMPA receptors by cellular prion protein and copper ions
por: Sun Huang, et al.
Publicado: (2018-10-01)

Differential expression of AMPA subunits induced by NMDA intrahippocampal injection in rats
por: Helene Aparecida Fachim, et al.
Publicado: (2016-02-01)

Memantine, an antagonist of the NMDA glutamate receptor, affects cell proliferation, differentiation and the intracellular cycle and induces apoptosis in Trypanosoma cruzi.
por: Flávia Silva Damasceno, et al.
Publicado: (2014-02-01)

A new model of temporary focal neocortical ischemia in the rat.
por: Buchan, A, et al.
Publicado: (1992)

NMDA receptor antagonists in the treatment of patients with vascular cognitive imprairments
por: I.S. Preobrazhenskaya
Publicado: (2014-10-01)

NMDA and AMPA Receptors at Synapses: Novel Targets for Tau and α-Synuclein Proteinopathies
por: Maria Italia, et al.
Publicado: (2022-06-01)

Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler mice
por: Corsi Massimiliano M, et al.
Publicado: (2006-10-01)

Synergy of AMPA and NMDA receptor currents in dopaminergic neurons: a modeling study
por: Denis eZakharov, et al.
Publicado: (2016-05-01)

NMDA and Ampa receptors in synaptic membranes of cocaine and cocaine-prazosin treated rats
por: W. I. Silva, et al.
Publicado: (2005-03-01)

Expression and roles of glutamate (NMDA) receptors on T cell subsets
por: Orihara Kanami, et al.
Publicado: (2010-11-01)